Chimica nella Scuola

Dare voce agli studenti e ai giovani

Vol. 1 No. 1 (2026): Chimica nella Scuola n. 1 2026

Carcinoma mammario: tra prevenzione e ricerca

  • Emine Tasan
DOI:
https://doi.org/10.1473/0nennb69
Submitted
7 April 2026
Published
7 April 2026

Abstract

Imagine a woman touching her breast and discovering a small lump. Behind that simple gesture, there is a world of science, prevention and courage. Breast cancer is the most commonly diagnosed cancer in women worldwide. Addressing risk factors, such as obesity, and adopting a healthy lifestyle are key strategies to prevent this disease. Epidemiological studies have shown that obesity significantly increases the modifiable risk of developing breast cancer, particularly after menopause, when adipose tissue becomes a real source of estrogen, which promotes the development of some forms of cancer. But this story must also be linked to the hard work of women scientists who, defying all barriers and prejudices, have given great help to research and treatment. They have demonstrated that being a woman and a scientist is not an exception, but a valuable force for progress. This article aims to offer a reflection on researchers who have dedicated themselves to ambitious projects channelling their passion at the service of science and women’s health and well-being.

References

  1. [1] L. C. Hartmann, T. A. Sellers, M. H. Frost, et al., Benign breast disease and the risk of breast cancer, New England Journal of Medicine, 2005, 353(3), 229-237.
  2. [2] Fondazione AIOM, AIRTUM, Centro Nazionale di Prevenzione delle Malattie e Promozione della Salute, I numeri del cancro in Italia, Intermedia editore, 2020.
  3. [3] Organizzazione mondiale della sanità (OMS), 2021 (https://www.biodiritto.org/Biolaw-pedia/Docs/Rapporto-OMS-2021-World-Health-Statistics-Monitoring-Health-for-the-Sustainable-Development-Goal).
  4. [4] C. Katsura, I. Ogunmwonyi, H. K. Kankam, S. Saha, Breast cancer: presentation, investigation and management, British Journal of Hospital Medicine, 2022, 83(2), 1-7.
  5. [5] M. M. Fonseca, L. R. Lamb, R. Verma, et al., (2019). Breast pain and cancer: should we continue to work-up isolated breast pain?, Breast Cancer Research and Treatment, 2019, 177(3), 619-627.
  6. [6] S. R. Lakhani, I. O. Ellis, S. Schnitt, et al., WHO Classification of Tumours of the Breast, 2012 (https://publications.iarc.who.int/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-The-Breast-2012).
  7. [7] J. D. Brierley, M. K. Gospodarowicz, C. Wittekind, TNM. Classification des tumeurs malignes, 2017 (http://mom.gov.az/resources/content_files/ebook/TNM-Classification-of-Malignant-Tumours-8th-edition.pdf).
  8. [8] O. H. Beahrs, Staging of cancer of the breast as a guide to therapy, Cancer, 1984, 53(S3), 592-594.
  9. [9] N. Harbeck, M. Gnant, Interpretation of the evidence for the efficacy and safety of statin therapy, Lancet, 2017, 389(10074), 1134-1150.
  10. [10] O. A. Martin, R. F. Martin, Cancer radiotherapy: understanding the price of tumor eradication, Frontiers in cell and developmental biology, 2020, 8, 261.
  11. [11] V. T. Devita, S. Hellman, S. A. Rosenberg (Eds.), Cancer: principles and practice of oncology, Lippincott Williams & Wilkins Publishers, 2001.
  12. [12] M. Giuliano, R. Schiff, C. K. Osborne, M. Trivedi, Biological mechanisms and clinical implications of endocrine resistance in breast cancer, The Breast, 2011, 20, S42-S49.
  13. [13] M. Chang, Tamoxifen resistance in breast cancer, Biomolecules & Therapeutics, 2012, 20(3), 256.
  14. [14] Y. Yarden, M. X. Sliwkowski, Untangling the ErbB signalling network, Nature Reviews Molecular Cell Biology, 2001, 2(2), 127-137.
  15. [15] D. Hanahan, R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, 2011, 144(5), 646-674.
  16. [16] J. A. Joyce, J. W. Pollard, Microenvironmental regulation of metastasis, Nature Reviews Cancer, 2009, 9(4), 239-252.
  17. [17] D. F. Quail, J. A. Joyce, Microenvironmental regulation of tumor progression and metastasis, Nature Medicine, 2013, 19(11), 1423-1437.
  18. [18] P. Mishra, D. Banerjee, A. Ben-Baruch, Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy, Journal of Leukocyte Biology, 2011, 89(1), 31-39.
  19. [19] R. E. Coleman, W. Gregory, H. Marshall, et al., The metastatic microenvironment of breast cancer: clinical implications, The Breast, 2013, 22, S50-S56.
  20. [20] M. Ewertz, M. B. Jensen, K. Á. Gunnarsdóttir, et al., Effect of obesity on prognosis after early-stage breast cancer, Journal of Clinical Oncology, 2011, 29(1), 25-31.
  21. [21] M. Harvie A. Howell, Energy balance adiposity and breast cancer: impact of obesity and caloric intake on cancer risk and recurrence, Future Oncology, 2012, 8(9), 999-1014.
  22. [22] G. Block, B. Patterson, A. Subar, Fruit, vegetables, and breast cancer risk: a review of the epidemiological evidence, Nutrition and Cancer, 1992, 18(1), 1-29.
  23. [23] A. Bleyer, H. G. Welch, Effect of three decades of screening mammography on breast-cancer incidence, New England Journal of Medicine, 2012, 367(21), 1998-2005.
  24. [24] K. Metcalfe, S. Gershman, H. T. Lynch, et al., Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers, British Journal of Cancer, 2011, 104(9), 1384-1392.
  25. [25] Cuzick J., et al., Overview of the main outcomes in breast-cancer prevention trials, The Lancet, 2003, 361(9354), 296-300.
  26. [26] M. C. King, J. H. Marks, J. B. Mandell, Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2, Science, 2003, 302(5645), 643-646.